Examples of using Luminity in English and their translations into German
{-}
-
Medicine
-
Colloquial
-
Official
-
Ecclesiastic
-
Financial
-
Ecclesiastic
-
Political
-
Computer
-
Programming
-
Official/political
-
Political
What is Luminity?
Luminity contains sodium.
Other information about Luminity.
What Luminity contains.
Other medicines and Luminity.
How has Luminity been studied?
Three studies looked at its ability to enhance the image of the left ventricle,comparing the echocardiography scan before and after administration of Luminity.
It is not known whether Luminity is excreted in human breast milk.
Luminity should not be used in children and adolescents(under 18 years of age) as it has not been studied in these groups.
In two of these studies, Luminity was compared with placebo a dummy treatment.
Luminity should not be used in patients below 18 years as efficacy and safety in these groups have not been established.
Before activation(shaking) the contents of the vial, Luminity appears as a colourless, uniformly clear to translucent liquid.
The way Luminity is given and the dose depend on the technique used for the echocardiography.
If you have had an allergic reaction in the past with Luminity or any other ultrasound contrast agent tell your doctor.
Before administering Luminity, the medicinal product must be activated by using a mechanical shaking device, the Vialmix, see section 6.6.
Three studies looked at its effectiveness in enhancing the image of the left ventricle,comparing the echocardiography scan before and after administration of Luminity.
The Vialmix is not included in the Luminity pack but will be provided to healthcare professionals upon ordering the pack.
As Luminity consists of microspheres that are stable and small enough for transpulmonary passage, enhanced echo signals in the left heart and systemic circulation are obtained.
As experience is limited in patients with certain severe states of cardiac andpulmonary diseases, Luminity should be used only after careful consideration and such use should be monitored closely during administration.
Before use, Luminity must be activated by shaking it using a mechanical device called Vialmix, which is supplied to doctors who need to prepare the medicine.
The last two studieswere set up primarily to look at the effectiveness of Luminity in improving the accuracy of the measurement of the ejection fraction the percentage of the blood volume that is pumped out of the heart in one beat.
Luminity is used in adults to obtain a clearer scan of the chambers of the heart, especially of the left ventricle, during echocardiography a diagnostic test where an image of the heart is obtained using ultrasound.
The reported adverse reactions following the use of Luminity in pivotal and supportive trials(total of 2,526 patients) occur within minutes after administration and usually resolve without therapeutic intervention within 15 minutes.
Luminity is used in patients with suspected or confirmed coronary artery disease(obstruction of the blood vessels supplying the heart muscle), when the image obtained with non- contrast echocardiography is not optimal.
The reported adverse reactions following the use of Luminity in pivotal and supportive trials(total of 2,526 patients) have generally been mild to moderate in intensity, occur within minutes after administration and usually resolve without therapeutic intervention within 15 minutes.
Luminity is used in adults to obtain a clearer image of the chambers of the heart, especially of the left ventricle, during echocardiography a diagnostic test where an image of the heart is obtained using ultrasound.
As Luminity has no pharmacologic effect, and on the basis of its pharmacokinetic and pharmacodynamic profiles, no or negligible influence is expected with the use of this product on the ability to drive or use machines.
Luminity is then given into a vein either as a‘bolus' injection(given all at once) or as an infusion(drip solution) after being diluted with sodium chloride 9 mg/ml(0.9%) or glucose 50 mg/ml(5%) solution for injection.
Luminity should be used only after careful consideration and such use should be monitored closely during administration in patients with adult respiratory distress syndrome, endocarditis, a heart with prosthetic valves, acute states of systemic inflammation or sepsis, known states of hyperactive coagulation and/or recurrent thromboembolism.